These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27003827)

  • 21. Active-comparator design and new-user design in observational studies.
    Yoshida K; Solomon DH; Kim SC
    Nat Rev Rheumatol; 2015 Jul; 11(7):437-41. PubMed ID: 25800216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Research Methodology 2: Observational Clinical Research.
    Sessler DI; Imrey PB
    Anesth Analg; 2015 Oct; 121(4):1043-1051. PubMed ID: 26378704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Developing process of guide on methodological standards in pharmacoepidemiology (T/CPHARMA 002-2019)].
    Xu Y; Ding CY; Zhuo L; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Oct; 40(10):1186-1190. PubMed ID: 31658514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness Research in Inflammatory Bowel Disease: A Necessity and a Methodological Challenge.
    Salleron J; Danese S; D'Agay L; Peyrin-Biroulet L
    J Crohns Colitis; 2016 Sep; 10(9):1096-102. PubMed ID: 26944416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-Based Observational Studies in Oncology: Proceed With Caution.
    Soni PD; Spratt DE
    Semin Radiat Oncol; 2019 Oct; 29(4):302-305. PubMed ID: 31472729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for time-varying exposure related problems in pharmacoepidemiology: An overview.
    Pazzagli L; Linder M; Zhang M; Vago E; Stang P; Myers D; Andersen M; Bahmanyar S
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):148-160. PubMed ID: 29285840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods in epidemiology: observational study designs.
    DiPietro NA
    Pharmacotherapy; 2010 Oct; 30(10):973-84. PubMed ID: 20874034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When should case-only designs be used for safety monitoring of medical products?
    Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology.
    Osborne V; Lane S; Shakir SAW
    Drug Saf; 2021 Aug; 44(8):835-841. PubMed ID: 33961212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics.
    Luo X; Doherty J; Cappelleri JC; Frush K
    Curr Med Res Opin; 2007 Nov; 23(11):2607-15. PubMed ID: 17854515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
    Etminan M; Samii A
    Pharmacotherapy; 2004 Aug; 24(8):964-9. PubMed ID: 15338844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Studies 1: Determinants of Risk.
    Murphy SW
    Methods Mol Biol; 2021; 2249():83-101. PubMed ID: 33871840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.
    Wang SV; Schneeweiss S; Maclure M; Gagne JJ
    Am J Epidemiol; 2014 Sep; 180(6):636-44. PubMed ID: 25086050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example.
    Harvey RA; Hayden JD; Kamble PS; Bouchard JR; Huang JC
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):368-377. PubMed ID: 27859943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observational Study Design in Veterinary Pathology, Part 1: Study Design.
    Caswell JL; Bassel LL; Rothenburger JL; Gröne A; Sargeant JM; Beck AP; Ekman S; Gibson-Corley KN; Kuiken T; LaDouceur EEB; Meyerholz DK; Origgi FC; Posthaus H; Priestnall SL; Ressel L; Sharkey L; Teixeira LBC; Uchida K; Ward JM; Webster JD; Yamate J
    Vet Pathol; 2018 Sep; 55(5):607-621. PubMed ID: 30071806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness research in cancer with observational data.
    Giordano SH
    Am Soc Clin Oncol Educ Book; 2015; ():e330-5. PubMed ID: 25993193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities.
    Cameron C; Fireman B; Hutton B; Clifford T; Coyle D; Wells G; Dormuth CR; Platt R; Toh S
    Syst Rev; 2015 Nov; 4():147. PubMed ID: 26537988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association.
    Gruber S; Chakravarty A; Heckbert SR; Levenson M; Martin D; Nelson JC; Psaty BM; Pinheiro S; Reich CG; Toh S; Walker AM
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):973-81. PubMed ID: 27418432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Core concepts in pharmacoepidemiology: Measurement of medication exposure in routinely collected healthcare data for causal inference studies in pharmacoepidemiology.
    Thai TN; Winterstein AG
    Pharmacoepidemiol Drug Saf; 2024 Mar; 33(3):e5683. PubMed ID: 37752827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safe Expectations: Current State and Future Directions for Medication Safety in Pregnancy Research.
    Wood ME; Andrade SE; Toh S
    Clin Ther; 2019 Dec; 41(12):2467-2476. PubMed ID: 31563392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.